| 常用名 | 申达奇单抗 | CAS号 | 2151032-62-9 |
|---|---|---|---|
| 价格 | ¥需询单/100ug ¥需询单/500ug | 纯度 | 95.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis)[1]. 物理化学性质: CAS号:2151032-62-9 常用中文名:申达奇单抗 常用英文名:Cendakimab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |